Want to see HK:0853 full AI Analyst Report?
MicroPort Scientific (0853) Stock Price & Analysis
0853 Stock Chart & Stats
- Day’s Range
- HKD 5.88 - HKD 6.22
- 52-Week Range
- HKD 5.83 - HKD 14.16
- Previous Close
- HKD 6.08
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- HKD 11.65B
- Enterprise Value
- HKD 30.59B
- Total Cash (Recent Filing)
- HKD 813.82M
- Total Debt (Recent Filing)
- HKD 1.60B
- Price to Earnings (P/E)
- 31.2
- Beta
- 1.29
- Next Earnings
- Apr 01, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Jun 28, 2021
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Diversified Medical-device Portfolio And International Reach
Exposure across cardiovascular, orthopedic and other device categories can diversify procedure-driven revenue and reduce dependence on one product franchise. International sales and distribution also broaden commercialization opportunities beyond China, supporting a more resilient business model over the next several quarters.
Healthy Gross Margin And Improving Profitability
A roughly 56% gross margin indicates meaningful value capture in the product portfolio, while the return to positive net income shows substantial improvement from prior losses. If maintained, this profitability base can support investment in product development and commercial expansion.
Balance-sheet Repair And Restored Shareholder Returns
The sharp reduction in debt relative to equity improves financial flexibility compared with 2024, while positive ROE signals that rebuilt equity is beginning to generate returns. This repair strengthens the platform for funding operations and pursuing growth, despite leverage remaining elevated.
Bears Say
Revenue Contraction Signals An Incomplete Turnaround
Revenue contraction indicates that the return to accounting profitability has not yet been accompanied by renewed top-line momentum. Persistent weakness in sales can limit operating leverage, reduce the resources available for innovation, and make the broader turnaround less durable over the next several months.
Negative Free Cash Flow Remains A Major Weakness
Materially negative free cash flow means reported earnings are not yet translating into internally generated funding. This can constrain investment and debt reduction, while requiring greater reliance on existing liquidity or financing until operating cash generation becomes consistently stronger.
Elevated Leverage And Negative Operating Profit
Although leverage improved, debt remains high relative to equity while operating profit is still negative. That combination leaves less room for execution setbacks and makes sustained earnings improvement important, because interest and operating demands may continue to restrict financial flexibility.
MicroPort Scientific News
0853 FAQ
What was MicroPort Scientific’s price range in the past 12 months?
What is MicroPort Scientific’s market cap?
When is MicroPort Scientific’s upcoming earnings report date?
How were MicroPort Scientific’s earnings last quarter?
Is MicroPort Scientific overvalued?
Does MicroPort Scientific pay dividends?
What is MicroPort Scientific’s EPS estimate?
How many shares outstanding does MicroPort Scientific have?
What happened to MicroPort Scientific’s price movement after its last earnings report?
Which hedge fund is a major shareholder of MicroPort Scientific?
What is the TipRanks Smart Score and how is it calculated?
MicroPort Scientific Stock Smart Score
Company Description
MicroPort Scientific
MicroPort Scientific Corp. is an investment holding company, which engages in the research and development, manufacture, and distribution of medical devices. It operates through the following segments: Cardiovascular Devices Business, Orthopedics Devices Business, Cardiac Rhythm Management Business, Endovascular and Peripheral Vascular Devices Business, Neurovascular Devices Business, Surgical Devices Business, Heart Valve Business, Surgical Robot Devices Business, and Others. The Cardiovascular Devices Business segment offers integrated medical solutions for the treatment of coronary artery-related diseases, develops, manufactures, and commercializes coronary stents and related delivery systems, along with balloon catheters, passive accessories and active devices, in fulfilling the overall demands of doctors and patients worldwide. The Orthopedics Devices Business segment is involved in the total solutions for the treatment of orthopedic problems, with an extensive range of orthopedics products that include reconstructive joints, spine and trauma products, and other professional implants and instruments. The Cardiac Rhythm Management Business segment develops, manufactures, and markets of products for the diagnosis, treatment, and management of heart rhythm disorders and heart failure, with products covering pacemakers, defibrillators, and cardiac resynchronization therapy devices. The Endovascular and Peripheral Vascular Devices Business segment focuses on providing integrated disease solutions for aortic and peripheral vascular diseases such as thoracic and abdominal aortic aneurysm, aortic dissection, atherosclerosis, and lower extremity arteriosclerotic occlusion. The Neurovascular Devices Business segment specializes in providing total solutions for the treatment of neurovascular diseases, including hemorrhagic stroke, cerebral atherosclerotic stenosis, and acute ischemic stroke, continuously focused on research and development, production and commercialization of neurovascular therapeutic and access devices. The Surgical Devices Business segment provides overall solutions for cardiac surgery and emergency life support. The Heart Valve Business segment includes sale, manufacture, research, and development of heart valve devices. The Surgical Robot Devices Business segment designs, develops, and commercializes innovative surgical robots. The company was founded by Zhao Hua Chang in 1998 and is headquartered in Shanghai, China.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Jonathan W. Chen
- Employees
- 6,547
- Website
- www.microport.com
- Address
- 1601 Zhangdong Road, Shanghai, SH, 201203, CN
MicroPort Scientific (0853) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 3 | 5 | 12 |
| Technical Analysis | 1 | 5 | 2 |
| Moving Averages | 2 | 0 | 10 |







